Surgery Partners (SGRY) Stock Price

Surgery Partners Price

NASDAQ·CLOSED
13.76
​
Market closed

Revenue has compounded at 23.2% per year over the past 14 years to 3.31 B USD. Earnings per share have declined at 43.4% per year over the last 4 years. Surgery Partners's net margin stands at -2.4%, broadly stable from -3.2% several years earlier. Analysts set a median price target of 18.50 USD, implying 34.4% above the current price. Of 18 analysts, 14 rate the stock a buy — an overall Buy consensus.

Surgery Partners stock price

Access this data via the Eulerpool API

Surgery Partners business model & stock analysis

Surgery Partners Inc is an American company specializing in specialized surgical services in the United States. It was founded in 1997 and is headquartered in Nashville, Tennessee. The company focuses on outpatient surgical procedures, providing a variety of medical services including eye surgery, endoscopy, ENT surgery, gynecology, orthopedic surgery, plastic surgery, and urology. Surgery Partners has over 180 surgical centers and practices in 32 states. It expanded its services through the acquisition of Symbion Healthcare in 2017, offering anesthesia services, pain management, diagnostics, and laboratory services. The company also emphasizes excellent service and has partnerships with hospitals to expand its surgical services.

Frequently asked questions about Surgery Partners

Surgery Partners Inc is primarily active in the healthcare industry. With a focus on providing surgical services, the company operates a network of outpatient surgical facilities, physician practices, and anesthesia services. By offering a comprehensive range of surgical solutions, Surgery Partners Inc aims to improve patient outcomes and enhance healthcare delivery. With its expertise in specialties such as orthopedics, gastroenterology, and ophthalmology, the company plays a crucial role in meeting the diverse healthcare needs of patients across different regions. Overall, Surgery Partners Inc's activities support the advancement and accessibility of quality healthcare services.

The business model of Surgery Partners Inc centers around providing a comprehensive range of surgical services through its network of ambulatory surgery centers, surgical hospitals, and contract services. With a focus on delivering high-quality, cost-effective care, Surgery Partners Inc aims to meet the needs of patients, physicians, and healthcare facilities. By offering a diverse range of surgical specialties, including orthopedics, gastroenterology, and ophthalmology, Surgery Partners Inc strives to improve patient outcomes and satisfaction. Through its strategic partnerships and operational expertise, the company continues to expand its footprint and strengthen its position within the healthcare industry.

The main competitors of Surgery Partners Inc in the market include Tenet Healthcare Corporation, HCA Healthcare, and UnitedHealth Group.

Surgery Partners Inc is a leading healthcare services company with an extensive history in the industry. Established in 2004, Surgery Partners has since grown to become a prominent player in providing surgical services across the United States. With a focus on delivering high-quality care in a cost-effective manner, the company operates a network of surgical facilities and ancillary services centers. Through strategic partnerships, Surgery Partners offers a range of surgical procedures in various specialties, ensuring access to a wide range of patients in need. With their commitment to exceptional patient care, Surgery Partners Inc has established itself as a trusted name in the healthcare sector.

Surgery Partners Inc has achieved several significant milestones in its history. One notable accomplishment includes the strategic acquisition of National Surgical Healthcare in 2017, which expanded the company's reach and capabilities in the outpatient surgical market. Additionally, Surgery Partners Inc achieved recognition as a leader in ambulatory surgery, providing high-quality healthcare services across multiple states. The company has also demonstrated consistent growth and financial performance, further establishing its position in the healthcare industry. Surgery Partners Inc continues to prioritize patient care and innovation, driving its success and reinforcing its reputation as an esteemed company in the stock market.

Surgery Partners Inc is primarily present in the United States.

Surgery Partners Inc values the highest standards of patient care, innovation, and excellence in healthcare services. With a patient-centric approach, the company strives to provide the most advanced surgical solutions and personalized care. The corporate philosophy revolves around compassionate healthcare delivery, continuous improvement, and ethical practices. Surgery Partners Inc is committed to fostering strong relationships with physicians, patients, and partners, while maintaining a focus on operational efficiency and financial strength. The company's dedication to quality outcomes, cutting-edge technology, and commitment to patient satisfaction embodies its core values and corporate philosophy.

Analysts currently set an average price target of 18.75 USD for the Surgery Partners stock (median: 18.50 USD), implying +36.3 % versus the latest price. The consensus is based on 18 analyst ratings.

18 analysts currently rate the Surgery Partners stock: 14 recommend buying, 4 holding and 0 selling. For 2026, analysts expect Surgery Partners to generate revenue of 3.35 B USD and earnings per share of 0.40 USD.

Converted at the current exchange rate, the Surgery Partners share trades at 12.28 EUR (13.76 USD).

The Surgery Partners share (SGRY) is listed on 4 stock exchanges, including: NASDAQ (SGRY), Frankfurt (1SP.F), München (1SP.MU), Düsseldorf (1SP.DU).

Surgery Partners Inc. is a leading healthcare company that focuses on outpatient surgical centers and services for the healthcare industry. The company offers a variety of surgical and diagnostic services delivered on an outpatient basis. Surgery Partners Inc. operates over 180 facilities in 31 states in the USA and provides a wide range of surgical services. The business model of Surgery Partners Inc. is based on the goal of providing its patients with top-quality surgical services and continuous medical care at the highest level. The company has an extensive network of outpatient surgical centers and offers its patients a wide range of surgical and diagnostic services, including general surgery, orthopedics, ophthalmology, neurology, gastroenterology, gynecology, and many others. Surgery Partners Inc. also offers specialized procedures and services such as endoscopic examinations, imaging services, pain therapy, and rehabilitation. The company also operates an extensive diagnostic platform that includes advanced imaging technology and diagnostic procedures such as endoscopy and biopsy. The company also has a focus on the development and utilization of cutting-edge technology in surgery and diagnostics to ensure that patients receive excellent medical care. Surgery Partners Inc. also maintains extensive partnerships with healthcare providers and hospitals to enable better coordinated care. The company collaborates with numerous facilities to meet the needs of patients and provide them with a seamless healthcare experience. These partnerships allow Surgery Partners Inc. to expand its network of facilities and improve its services. Surgery Partners Inc. is also actively involved in research and development, working to develop new procedures and technologies to improve surgical services. The company has a strong team of researchers and physicians who continuously seek new opportunities to enhance surgery and diagnostics, thereby ensuring better healthcare. Overall, the business model of Surgery Partners Inc. is focused on providing top-quality surgical and diagnostic services on an outpatient basis. The company operates an extensive network of surgical facilities and offers a wide range of surgical and diagnostic services to meet the needs of its patients. Through healthcare partnerships and the use of cutting-edge technologies, Surgery Partners Inc. strives to provide better healthcare for its patients.

The expected revenue of Surgery Partners is 3.35 B USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Surgery Partners is 51.33 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Surgery Partners is currently 34.10. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Surgery Partners stock.

The price-to-sales ratio (P/S) of Surgery Partners is currently 0.52. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Surgery Partners stock.

The Eulerpool Quality Score for Surgery Partners is 3/10.

The ISIN of Surgery Partners is US86881A1007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Surgery Partners is A14YWP. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Surgery Partners is SGRY. The ticker symbol is used to trade Surgery Partners shares on the stock exchange.

Fair ValueTerminal
11.28 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
206,793.75 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
USD
Initial public offering
Oct 1, 2015
ISIN
US86881A1007
Cusip
86881A100
Sedol
BYTC1B2
Market capitalization
1.74 B USDSmall Cap
52-Week Range
PEG
-2.71
P/E ratio
P/Ee 2026
33.81
P/Ee 2027
31.94
P/Ee 2028
22.09
P/Ee 2029
24.57
P/S
P/Se
0.52
EV/EBIT
13.45
P/B Ratio
1.01
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-1.43 %
Last updated Oct 10, 2026, 4:33 AM

Surgery Partners Ticker

DÜSSELDORF · 1SP.DUFRANKFURT · 1SP.FMUNICH · 1SP.MUNASDAQ · SGRY

Surgery Partners FIGI

SGRY:US · BBG009T0TKV8SGRY:UA · BBG009T0TLN5SGRY:UC · BBG009T0TLP3SGRY:UN · BBG009T0TLR1SGRY:UP · BBG009T0TLS0SGRY:UB · BBG009T0TLV6SGRY:UM · BBG009T0TLX4SGRY:UX · BBG009T0TLY3SGRY:UD · BBG009T0TM35SGRY:UW · BBG009T0TM53SGRY:UF · BBG009T0TM62SGRY:VY · BBG009T0TM71